Feng Xu
Biomedical Engineering · with Li · 2014–2017
A researcher in the Science corpus: 2 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Biomedical Engineering — 27 citations into it
- Molecular Biology — 24 citations into it
Whom Feng Xu trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- George M. Whitesides (in Biomedical Engineering)
- Andres W. Martinez (in Biomedical Engineering)
Papers from Feng Xu's perspective
Ordered by how strongly the researchers Feng Xu trusts endorse each paper. Same corpus, a different order for every researcher.
- Lab-on-a-chip devices for global health: past studies and future opportunities. (Lab on a Chip)
- The challenge of emerging and re-emerging infectious diseases (Nature)
- The origins and the future of microfluidics (Nature)
- Microfluidic diagnostic technologies for global public health (Nature)
- Functional Nucleic Acid Sensors (Chemical Reviews)
- Paper-based ELISA. (Angewandte Chemie)
- Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. (Chemical Reviews)
- Preparation of aptamer-linked gold nanoparticle purple aggregates for colorimetric sensing of analytes (Nature Protocols)
- Isothermal nucleic acid amplification technologies for point-of-care diagnostics: a critical review. (Lab on a Chip)
- Paper-based nanobiosensors for diagnostics. (Chemical Society Reviews)
Their papers
- Advances in paper-based point-of-care diagnostics. (2014) — 884 citations
- Recent Advances of Controlled Drug Delivery Using Microfluidic Platforms (2017) — 306 citations